8270 — China CBM Co Income Statement
0.000.00%
- HK$160.08m
- HK$109.80m
- CNY47.08m
Annual income statement for China CBM Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | PRESS | PRESS |
| Standards: | HKAS | HKAS | HKAS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 215 | 327 | 239 | 21.1 | 47.1 |
| Cost of Revenue | |||||
| Gross Profit | -0.491 | 53.3 | 26.4 | 6.57 | 16.7 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 227 | 195 | 236 | 65.1 | 76.1 |
| Operating Profit | -12.2 | 132 | 3.36 | -44 | -29 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -20 | 129 | 2.1 | -44.3 | -47.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -19.7 | 122 | 2.15 | -49.2 | -46.7 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -2.24 | 127 | 2.53 | -34.6 | -60 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.24 | 127 | 2.53 | -34.6 | -60 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.081 | 0.045 | -0.004 | -0.089 | -0.119 |
| Special Dividends per Share |